Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_assertion type Assertion NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_head.
- NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_assertion description "[Second, promising next-generation agents target the MM cell in its microenvironment (eg, deubiquitinating enzyme inhibitors; chymotryptic [carfilzomib, Onyx 0912, MLN 9708] and broader [NPI-0052] proteasome inhibitors; immunoproteasome inhibitors; and pomalidamide).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_provenance.
- NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_assertion evidence source_evidence_literature NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_provenance.
- NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_assertion SIO_000772 22215754 NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_provenance.
- NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_assertion wasDerivedFrom befree-2016 NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_provenance.
- NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_assertion wasGeneratedBy ECO_0000203 NP950748.RAAy__9oykRZRc3WWy5pdI7u5XszBA9XnDb7oPBA8F0uE130_provenance.